Artificial intelligence is gaining momentum in many industries, where it helps businesses achieve various milestones. In the pharma industry, is also being used to achieve various business related measures, ensuring safety and supplying high quality products.
For the pharma regulators, it is also being accepted as a tool to provide better output and considerably reduce different errors. Additionally, regulatory bodies are also devising regulations to better utilize AI in the pharmaceutical industry
World Health Organization is an international reputable body that provides best practices for the pharma industry worldwide, and is independent of any local regulatory bodies worldwide. For the AI, it also provide guidelines for using it in medical devices and clinical practice. These guidelines aim to highlight the risks that this new technology poses, and their relevant best practices
Before explaining this guideline, let's discuss how professionals implement the AI and what the position of AI is in the pharmaceutical industry.
Examples of AI in the Pharma industry
Some area that AI is being implemented in pharma industry include the following
Manufacturing
AI can be used in manufacturing to improve the processes by utilizing it as a historical trend to design optimum process values.
Application of AI also helps to reduce waste during manufacturing, by detecting and predicting errors in the process, and defining optimum machine values.
Drug Discovery
AI can be used in drug Discovery for analyzing human specific problems, and using the information obtained to predict optimum chemical composition and therapies. It also helps to improve existing therapies by analyzing the historical pattern of effectiveness and detect anomalies and apply improvements
Research
AI can be used to automate data collection by researchers, and translating them into meaningful information. The data in pharmaceutical research is enormous, and can become difficult and inefficient to translate it into the information through manual process.
The AI can solve this problem, by automating the process and integrating historical data with current data to analyze and predict accurate information
What regulatory body think about the potential of AI for pharma industry?
In this section, we discussed what regulatory body thinks about artificial intelligence
AI has the potential
Many regulatory bodies considered AI having a great potential to transform healthcare. They help to provide an insight into current manufacturing processes, and provides a wealth of information about a specific field area, or application.
Regulatory bodies also understand that AI, and technology like these can help achieve the objectives of accurate, safe and patient centric products
Helps to streamline regulatory process
Regulatory bodies are of the view that AI can streamline compliance process for an organization by providing the necessary data, proving the implementation of the required processes and following recommended practices. AI can also help pharma manufacturers in achieving compliance by fulfilling requirements in less time that could take a lot more time without using AI
For the manufacturing organization, AI can streamline the entire elements of manufacturing by utilizing historical data and producing the ongoing process in an efficient manner. For a clinical research organization, AI can automate the data analysis, and can use this historical data to predict effective drug improvements in an existing drug and reducing the time consumed by traditional research practices.
All the four mention circumstances helps an organization to complete the regulatory body regulations in an efficient manner
Regulatory bodies proposing and updating their regulatory guidelines
Regulatory bodies are accepting the use of AI in pharma industry and proposing new guidelines. They continuously update themselves to provide guidance for better application of this tech...
(All Rights Reserved)